LCN2 and acute kidney injury: The TRIBE-AKI study combined a biomarker and clinical model, and found that adding clinical model significantly but only modestly raised the AUROC of urine IL-18 and plasma NGAL from 0.74 to 0.76 (P = .03) and 0.70 to 0.75 (P = .01), respectively.